IOLCP

Ludhiana, India Founded: 1986 • Age: 40 yrs Listed
Active pharmaceutical ingredients and specialty chemicals are manufactured.
Request Access
Report Incorrect Data
Page last updated

About IOLCP

IOLCP is a publicly listed company based in Ludhiana (India) founded in 1986. Active pharmaceutical ingredients and specialty chemicals are manufactured. The company has 3,112 employees. Its chief executive, as recorded, is Vikas Vij. Its Indian entity Iol Chemicals And Pharmaceuticals Limited reported revenue of ₹2,340 Cr. Its focus areas include Chemicals and Materials, Diversified Chemicals and Speciality Chemicals.

Company details

IOLCP was established in 1986 in Ludhiana, India, within the pharmaceutical and chemical sectors. Active pharmaceutical ingredients, lifestyle drugs, specialty chemicals, and pain management chemicals are produced. Emphasis is given to generic product development and cost-effective commercialization. Ten APIs have been commercialized, with ten others in advanced development. Ethyl acetate is manufactured from organic alcohol for applications in flexible packaging, pharmaceuticals, textiles, food processing, pesticides, and paints.

  • Headquarters Ludhiana, India
  • Employees 3,112
  • Stage Public
  • Sectors
    Chemicals & Materials
  • Website iolcp.com
  • Social LinkedIn Instagram YouTube
  • Legal Name Iol Chemicals & Pharmaceuticals Ltd.
Operational Areas
Chemicals & Materials → Core & Diversified Chemicals
Key Metrics
  • Market Cap
    ₹5,409 Cr

    IOLCP · NSE

  • Share Price
    ₹202.95

    +10.13% today

  • Revenue
    ₹2,319 Cr

    FY 2025-26 · +11.5% YoY

  • EBITDA
    ₹258 Cr

    Margin 11.1%

  • Net Profit
    ₹147 Cr

    FY 2025-26 · +44.8% YoY

  • P/E (TTM)
    25.4x

    P/B 2.8x

  • ROE
    7.9%

    ROCE 10.6%

  • Debt / Equity
    0.07

    Interest cover 8.2x

  • Employee Count
    3,112

Apps and channels of IOLCP

its YouTube channel IOL CHEMICALS AND PHARMACEUTICALS LIMITED has 1.52K subscribers and 29 videos.

IOL CHEMICALS AND PHARMACEUTICALS LIMITED
YouTube 1.52K subscribers 29 videos News & Politics
Open channel

Videos from IOLCP

The most watched videos on IOLCP's YouTube channel, IOL CHEMICALS AND PHARMACEUTICALS LIMITED (1.52K subscribers). Click a video to play it here.

Interview of Mr Vijay Garg, Joint MD, IOLCP, discussing Company's Business Prospects for FY2021.
9.6K views
Interview of Mr Vijay Garg, Joint MD, IOLCP Talking on IOLCP Business Growth Plans for FY2021
7.1K views
Sustainable growth of IOLCP's API and Chemical segments will continue
5K views
Interview of Mr Vijay Garg, JMD, IOLCP on Zee Business talking Company's Q1 Results and Performance
4.2K views

More on IOL CHEMICALS AND PHARMACEUTICALS LIMITED.

Board of directors of Iol Chemicals And Pharmaceuticals Limited (IOLCP)

Iol Chemicals And Pharmaceuticals Limited is the primary company behind IOLCP. The board of Iol Chemicals And Pharmaceuticals Limited currently have 8 directors; the longest-serving is Varinder Gupta, appointed in 1986. 21 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Varinder Gupta
DIN 00044068
Managing Director13 Nov 198639 yrs 11 moIol Chemicals And Pharmaceuticals Limited
Vikas Gupta
DIN 07198109
Whole-time director29 May 201511 yrs 5 moIol Chemicals And Pharmaceuticals Limited
Harpal Singh
DIN 06658043
Director06 Feb 20197 yrs 9 moIol Chemicals And Pharmaceuticals Limited
Rajender Mohan Malla
DIN 00136657
Director06 Feb 20197 yrs 9 moIol Chemicals And Pharmaceuticals Limited
Kushal Kumar Rana
DIN 09189020
Whole-time director04 Jun 20215 yrs 5 moIol Chemicals And Pharmaceuticals Limited
Sharad Tyagi
DIN 00371842
Director30 May 20224 yrs 5 moIol Chemicals And Pharmaceuticals Limited
Abhiraj Gupta
DIN 08204917
Whole-time director03 Apr 20233 yrs 7 moIol Chemicals And Pharmaceuticals Limited
Rajni Jha
DIN 10818947
Director28 Oct 20242 yrsIol Chemicals And Pharmaceuticals Limited

People of IOLCP

36 people are tracked at IOLCP (12 in leadership, 5 in board & advisors, 19 in team); the tracked headcount is 3,112.

NameRoleGroup
Vikas Vij
CEOLeadership
Varinder Gupta
Managing DirectorLeadership
Durgesh Pandey
Associate General Manager SAP S4 HanaLeadership
Devender Singh
Associate Vice President EHS & SustainabilityLeadership
Sanjeev Dua
Associate Vice PresidentLeadership
Dr Sushil Kumar Sharma
Vice President RA / QALeadership
Abhiraj Gupta
Executive DirectorLeadership
Vikas Gupta
Joint Managing DirectorLeadership
Simarpreet Singh
Associate General ManagerLeadership
Varun Sood
General ManagerLeadership
Rubina Parmar Sodhi
Associate Vice President - HRLeadership
Bhupendra Kumar
Head Of LogisticsLeadership
Sharad Tyagi
Independent DirectorBoard & advisors
Rajender Mohan Malla
ChairmanBoard & advisors
Harpal Singh
DirectorBoard & advisors
Kushal Kumar Rana
DirectorBoard & advisors
Sandhya Mehta
DirectorBoard & advisors
Mandeep Singh
AGMTeam
Ajit Kumar
Co-generation Engineer (power Plant)Team
Mayur Motwani
Associate ManagerTeam

16 more people are available in the full profile.

Premium access

Complete people profiles for IOLCP

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of IOLCP

IOLCP is a publicly listed company on the NSE with ticker symbol IOLCP in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date08 Nov 2010
  • Listed onNSE: IOLCP
  • Listed entityIOL Chemicals & Pharmaceuticals Ltd.
  • Exchange sectorProcess industries
  • ISININE485C01029
  • Share price₹203.69 (+4.4% on the day) · 2026-10-14
  • Market capitalisation₹5,733 Cr
  • Price to earnings35.6
  • EPS (diluted, trailing year)₹5.73
  • Dividend yield0.51%
  • Volume (last session)2,355,404

Financials of IOLCP

Exchange-reported figures of Iol Chemicals And Pharmaceuticals Limited, the listed company behind IOLCP (NSE: IOLCP).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹2,319 Cr
+11.5% YoY
EBITDA
₹258 Cr
+27.4% YoY
Profit After Tax
₹147 Cr
+44.8% YoY
Net Worth
₹1,799 Cr
+6.6% YoY
Total Assets
₹1,945 Cr
+7.4% YoY
Total Debt
₹135 Cr
+15.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue2,3192,0792,1332,2172,184
Revenue growth+11.5%-2.5%-3.8%+1.5%-
EBITDA258202231226244
EBITDA margin+11.1%+9.7%+10.8%+10.2%+11.2%
Profit before tax184138182189225
Net profit147101134139179
Net profit margin+6.3%+4.9%+6.3%+6.3%+8.2%
EPS (₹)4.693.4422.9023.7028.56
Balance sheet
Total assets1,9451,8111,6511,5891,439
Net worth1,7991,6881,6121,5081,392
Total debt13511732.7679.8143.95
Cash & bank19820814321.83140
Net working capital667655590541609
Cash flow
Cash from operations21417929012293.05
Cash from investing(198)(154)(191)(120)(121)
Cash from financing(29.03)46.04(92.50)(4.11)(1.64)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue756619580568552528523526
Revenue growth (YoY)+37.1%+17.4%+10.9%+8.0%+9.8%---
Other income8.181.845.296.887.374.524.076.43
EBITDA10392.4746.0757.0862.1462.7646.8741.57
EBITDA margin+13.7%+14.9%+7.9%+10.1%+11.3%+11.9%+9.0%+7.9%
Depreciation21.3420.2920.1819.9919.7718.5518.6817.94
Interest3.643.213.633.484.234.034.464.12
Profit before tax86.6970.8127.5540.4945.5144.7027.8025.94
Tax22.2917.656.9710.5211.5813.287.276.79
Net profit64.4053.1620.5829.9733.9331.4220.5319.15
EPS (₹)2.191.810.701.021.161.073.503.26
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue2,3192,0792,1332,2172,1841,9671,894
Revenue growth+11.5%-2.5%-3.8%+1.5%+11.0%+3.8%-
EBITDA258202232227242592574
EBITDA margin+11.1%+9.7%+10.9%+10.2%+11.1%+30.1%+30.3%
Profit before tax184138183189223571533
Net profit147101135140177445361
Net profit margin+6.3%+4.9%+6.4%+6.3%+8.1%+22.6%+19.1%
EPS (₹)4.693.4423.0723.8428.2275.7263.51
Balance sheet
Total assets1,9451,8111,6511,5881,4371,267877
Net worth1,7981,6871,6111,5071,3901,260814
Total debt13511732.7679.8143.952.7359.49
Cash & bank19820814320.90138365155
Net working capital667655590540607719451
Cash flow
Cash from operations21417929012391.04380471
Cash from investing(198)(154)(191)(119)(121)(317)(184)
Cash from financing(29.03)46.04(92.50)(4.11)(1.64)(58.28)(272)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue756619580568552528523526
Revenue growth (YoY)+37.1%+17.4%+10.9%+8.0%+9.8%---
Other income8.181.745.296.887.374.524.076.43
Total expenses653527534510490465476484
EBITDA10492.5746.0657.1062.1562.9446.8741.56
EBITDA margin+13.7%+14.9%+7.9%+10.1%+11.3%+11.9%+9.0%+7.9%
Depreciation21.3220.2720.1719.9819.7518.5318.6617.93
Interest3.643.213.633.484.234.034.464.12
Profit before tax86.7770.8327.5540.5245.5444.9027.8225.94
Tax22.2917.656.9710.5211.5813.287.276.79

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 09 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue756619580568552528523526
Revenue growth (YoY)+37.1%+17.4%+10.9%+8.0%+9.8%---
Other income8.181.845.296.887.374.524.076.43
EBITDA10392.4746.0757.0862.1462.7646.8741.57
EBITDA margin+13.7%+14.9%+7.9%+10.1%+11.3%+11.9%+9.0%+7.9%
Depreciation21.3420.2920.1819.9919.7718.5518.6817.94
Interest3.643.213.633.484.234.034.464.12
Profit before tax86.6970.8127.5540.4945.5144.7027.8025.94
Tax22.2917.656.9710.5211.5813.287.276.79
Net profit64.4053.1620.5829.9733.9331.4220.5319.15
EPS (₹)2.191.810.701.021.161.073.503.26
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue2,3192,0792,1332,2172,184
Revenue growth+11.5%-2.5%-3.8%+1.5%-
Other income21.3822.4130.0725.6132.04
Total expenses2,0611,8771,9021,9911,940
Employee cost248217201168141
EBITDA258202231226244
EBITDA margin+11.1%+9.7%+10.8%+10.2%+11.2%
Depreciation80.2371.9962.9146.1643.26
Interest14.5514.7616.1016.478.29
Profit before tax184138182189225
Tax46.7236.8947.2249.5157.18
Net profit147101134139179
Net profit margin+6.3%+4.9%+6.3%+6.3%+8.2%
EPS (₹)4.693.4422.9023.7028.56
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital58.7158.7158.7158.7158.71
Reserves & surplus1,7401,6291,5531,4491,334
Shareholders' funds (net worth)1,7991,6881,6121,5081,392
Minority interest0.000.000.000.000.00
Secured loans13211732.7679.6342.75
Unsecured loans3.420.000.000.181.20
Total debt13511732.7679.8143.95
Total liabilities1,9451,8111,6511,5891,439
Assets
Gross block1,6321,5441,236994762
Net block1,1821,171933752561
Capital work in progress95.5421.9310189.64105
Investments20.9220.7120.2919.972.37
Inventories371361425326410
Sundry debtors603514471505470
Cash & bank balances19820814321.83140
Loans & advances51.5665.5877.9365.2058.77
Total current assets1,2241,1481,1179181,078
Total current liabilities557493527376470
Net working capital667655590541609
Total assets1,9451,8111,6511,5891,439
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash78.177.691.393.2332.34
Net cash from operating activities21417929012293.05
Net cash from investing activities(198)(154)(191)(120)(121)
Net cash from financing activities(29.03)46.04(92.50)(4.11)(1.64)
Net change in cash(12.82)70.486.30(1.84)(29.11)
Closing cash19820814321.83140
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+11.5%-2.5%-3.8%+1.5%-
EBITDA growth+27.4%-12.3%+2.2%-7.7%-
PBT growth+33.6%-24.1%-3.7%-16.1%+9997.0%
Net income growth+44.8%-24.7%-3.6%-22.0%-
Revenue CAGR (3Y)+1.5%-1.6%---
EBITDA CAGR (3Y)+4.5%-6.1%---
Profitability & leverage
Net income margin+5.9%+4.9%+6.3%+6.3%+7.7%
Return on capital employed+10.6%+8.8%+12.2%+13.5%+16.2%
Return on net worth+7.9%+6.1%+8.6%+9.6%+12.0%
Debt / equity0.070.050.040.040.03
Long-term debt / equity0.000.000.000.000.00
Interest cover8.2011.339.609.174.12
Efficiency & per share
Fixed asset turnover1.461.501.912.522.87
Inventory turnover6.345.295.686.035.33
Debtors turnover4.154.224.374.554.65
EPS (₹)4.693.4422.9023.7028.56
Dividend per share (₹)1.000.805.004.004.00
Book value per share (₹)61.2757.49274.49256.81237.15
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue756619580568552528523526
Revenue growth (YoY)+37.1%+17.4%+10.9%+8.0%+9.8%---
Other income8.181.745.296.887.374.524.076.43
Total expenses653527534510490465476484
EBITDA10492.5746.0657.1062.1562.9446.8741.56
EBITDA margin+13.7%+14.9%+7.9%+10.1%+11.3%+11.9%+9.0%+7.9%
Depreciation21.3220.2720.1719.9819.7518.5318.6617.93
Interest3.643.213.633.484.234.034.464.12
Profit before tax86.7770.8327.5540.5245.5444.9027.8225.94
Tax22.2917.656.9710.5211.5813.287.276.79
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue2,3192,0792,1332,2172,1841,9671,894
Revenue growth+11.5%-2.5%-3.8%+1.5%+11.0%+3.8%-
Other income21.2822.4030.0725.5732.0424.3016.02
Total expenses2,0611,8771,9011,9911,9421,3751,321
Employee cost24821720116814111697.20
EBITDA258202232227242592574
EBITDA margin+11.1%+9.7%+10.9%+10.2%+11.1%+30.1%+30.3%
Depreciation80.1771.9262.8546.1343.2638.9235.73
Interest14.5514.7616.1016.478.295.8320.93
Profit before tax184138183189223571533
Tax46.7236.8947.2249.5157.18127172
Net profit147101135140177445361
Net profit margin+6.3%+4.9%+6.4%+6.3%+8.1%+22.6%+19.1%
EPS (₹)4.693.4423.0723.8428.2275.7263.51
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital58.7158.7158.7158.7158.7158.7156.89
Reserves & surplus1,7401,6291,5531,4481,3321,202747
Shareholders' funds (net worth)1,7981,6871,6111,5071,3901,260814
Secured loans0.0011732.7679.6342.750.0055.99
Unsecured loans1350.000.000.181.202.733.50
Total debt13511732.7679.8143.952.7359.49
Total liabilities1,9451,8111,6511,5881,4371,267877
Assets
Gross block1,6321,5441,236995762677597
Net block1,1811,170933751561512469
Capital work in progress95.5421.9310189.6410548.2719.19
Investments21.1221.0120.5920.272.471.220.05
Inventories371361425326410295188
Sundry debtors603514471505470300272
Cash & bank balances19820814320.90138365155
Loans & advances51.5565.5777.9164.8158.7748.4856.16
Total current assets1,2241,1481,1179171,0761,009671
Total current liabilities557493527376470290220
Net working capital667655590540607719451
Total assets1,9451,8111,6511,5881,4371,267877
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash78.027.530.961.1232.3428.0913.41
Net cash from operating activities21417929012391.04380471
Net cash from investing activities(198)(154)(191)(119)(121)(317)(184)
Net cash from financing activities(29.03)46.04(92.50)(4.11)(1.64)(58.28)(272)
Net change in cash(12.73)70.496.57(0.16)(31.22)4.2514.68
Closing cash19820814320.90138365155
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.5%-2.5%-3.8%+1.5%+11.0%+3.8%-
EBITDA growth+27.6%-12.7%+2.2%-6.5%-59.1%+3.1%-
PBT growth+33.8%-24.5%-3.6%-15.0%-61.0%+7.2%+58.6%
Net income growth+45.0%-25.3%-3.5%-20.6%-60.3%+23.1%-
Revenue CAGR (3Y)+1.5%-1.6%+2.7%+5.4%+9.0%+26.0%+38.7%
EBITDA CAGR (3Y)+4.4%-5.9%-26.9%-26.7%-16.1%+70.4%+77.7%
Profitability & leverage
Net income margin+5.9%+4.9%+6.4%+6.3%+7.6%+22.6%+19.1%
Return on capital employed+10.6%+8.8%+12.3%+13.6%+17.1%+53.8%+67.5%
Return on net worth+7.9%+6.1%+8.7%+9.7%+12.5%+42.9%+56.1%
Debt / equity0.070.050.040.040.020.030.27
Long-term debt / equity0.000.000.000.000.000.000.15
Interest cover8.1911.339.559.134.161.053.89
Efficiency & per share
Fixed asset turnover1.461.501.912.523.043.093.44
Inventory turnover6.345.295.686.036.208.1510.07
Debtors turnover4.154.224.374.555.676.878.03
EPS (₹)4.693.4423.0723.8428.2275.7263.51
Dividend per share (₹)1.000.805.004.004.006.003.00
Book value per share (₹)61.2657.48274.46256.61236.80214.69141.36

Web traffic of IOLCP

The website of IOLCP (iolcp.com) receives about 7.3K visits a month.

  • Monthly visits
    7.3K

    ▼ 43.2% vs previous month

Similar websites

Websites whose visitors overlap most with IOLCP. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
satyawatichemicals.com
satyawatichemicals.com
100%
–
pharmaadda.in
pharmaadda.in
65%
#3,634,193–
DitchCarbon
ditchcarbon.com
51%
680.7K#870,402View details

Top companies in Core & Diversified Chemicals

3 companies that operate in the same segment as IOLCP (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
DFPCL
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Scimplify
Specialty chemicals are manufactured through integrated R&D and production processes.
2023Bengaluru, Karnataka, IndiaUSD 72.97 MUSD 23.86 M
Himadri Chemicals and Industries
Manufactures coal tar and basic industrial chemicals.
1987Kolkata, West Bengal, IndiaUSD 24 MUSD 515.01 M1,161
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Iolcp

IOL CP: Increases FY27 Guidance Significantly: Revenue Growth Target Raised To Over 25% From 15%; Capex Guidance Increased To ₹250 Crore From ₹200 Crore.
Exchange Update • 7 days ago
IOLCP: Q2 REVENUE 7.95B RUPEES VS 5.67B (YOY)
Exchange Update • 10 days ago
IOLCP: Q2 SL NET PROFIT 650M RUPEES VS 300M (YOY)
Exchange Update • 10 days ago
IOLCP: Q2 EBITDA 1.1B RUPEES VS 565M (YOY); Q2 EBITDA MARGIN 13.73% VS 9.97% (YOY)
Exchange Update • 10 days ago
IOL Chemicals And Pharmaceuticals Limited: Obtains Certificate Of Suitability From EDQM For Fenofibrate - Process II, Boosting Regulatory Portfolio And Aiding Supply In Regulated Markets.
Exchange Update • 1 month ago
IOL Chemicals to Invest ₹350 Crore for Ibuprofen Production Expansion and Diversification
CNBC-TV18 • 2 months ago
Trade Spotlight: How should you trade IOL Chemicals, Poonawalla Fincorp, ICICI Prudential AMC, Eicher Motors, Clean Science, and others on August 14?
Moneycontrol • 2 months ago
IOL Chemicals And Pharmaceuticals June-Quarter Consol Profit 644 Million Rupees
Reuters • 3 months ago
Indian shares seen muted as US inflation relief offsets Mideast tensions
Reuters • 3 months ago
IOL Chemicals and Pharmaceuticals Gets Approval From NMPA, China For Clopidogrel Bisulfate API
Reuters • 3 months ago
Premium access

Complete news archive for IOLCP

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about IOLCP

IOLCP was founded in 1986.

IOLCP is headquartered in Ludhiana, India. It is registered at Ludhiana, Punjab, India.

Vikas Vij is the CEO of IOLCP, as recorded in our data.

IOLCP has 3,112 employees.

The primary company behind IOLCP, Iol Chemicals And Pharmaceuticals Limited, reported revenue of ₹2,340 Cr for FY 2026, up 12% year on year.

IOLCP was established in 1986 in Ludhiana, India, within the pharmaceutical and chemical sectors. Active pharmaceutical ingredients, lifestyle drugs, specialty chemicals, and pain management chemicals are produced. Emphasis is given to generic product development and cost-effective commercialization. Ten APIs have been commercialized, with ten others in advanced development. Ethyl acetate is manufactured from organic alcohol for applications in flexible packaging, pharmaceuticals, textiles, food processing, pesticides, and paints.

Yes, IOLCP is publicly traded on NSE under the ticker symbol IOLCP.

IOLCP operates through Iol Chemicals And Pharmaceuticals Limited.

The legal entities of IOLCP currently have 10 directors, including Harpal Singh, Rajender Mohan Malla, Abhay Raj Singh and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available